Tag Archives: medicine

Fab another little piece of my heart now, baby: 3D printing human organs

The idea of printing replacement biological tissue and organs has been around for a while – we mentioned the development the pressure-assisted spinning system back in 2007, in fact – but it looks like it’s finally reached the point where people think they can make a profit from it on a commercial scale. Via io9, The Economist tells us about Organovo and their US$200,000-a-pop commercially-available bio-printer:

To start with, only simple tissues, such as skin, muscle and short stretches of blood vessels, will be made, says Keith Murphy, Organovo’s chief executive, and these will be for research purposes. Mr Murphy says, however, that the company expects that within five years, once clinical trials are complete, the printers will produce blood vessels for use as grafts in bypass surgery. With more research it should be possible to produce bigger, more complex body parts. Because the machines have the ability to make branched tubes, the technology could, for example, be used to create the networks of blood vessels needed to sustain larger printed organs, like kidneys, livers and hearts.

I can’t wait to see what uses the street will find for this technology once it gets cheaper…

… no, scratch that. I think maybe I can wait after all.

We have the (experimental) technology; we can rebuild you!

cyborg headLost an ear during the Reservoir Dogs Re-enactment Society meeting? No problems – we’ll just grow you a new one on a nanocellulose framework [via NextBigFuture]:

Previously, Paul Gatenholm and his colleagues [at Chalmers University, Sweden] succeeded, in close co-operation with Sahlgrenska University Hospital, in developing artificial blood vessels using nanocellulose, where small bacteria “spin” the cellulose.

In the new programme, the researchers will build up a three-dimensional nanocellulose network that is an exact copy of the patient’s healthy outer ear and construct an exact mirror image of the ear. It will have sufficient mechanical stability for it to be used as a bioreactor, which means that the patient’s own cartilage and stem cells can be cultivated directly inside the body or on the patient, in this case on the head.

“As yet we do not know if it will work. It is an extremely exciting project that brings together expertise in image analysis, prototype manufacturing, biomechanics, biopolymers and cell biology. If we succeed it will open up a whole range of new and exciting areas of use.”

And while we’re speaking about ears, did you ruin your frequency response curve watching avant-noise bands play dingy bars and lofts in eighties New York*? You’ll be needing a hearing aid, then… but not some ugly uncool thing lodged in your ear canal. We’ve got one that’ll slip over one of your back teeth [via BoingBoing]:

There are other hearing aid devices that utilize bone conduction. Most, however, use a titanium pin drilled into the jaw bone (or skull) to transmit sound to the cochlea. SoundBite seems to be the first non-surgical, non-invasive, easily removable device. While they are likely years from retail production, Sonitus Medical plans on having SoundBite ITMs fitted to each individual’s upper back teeth and fabricated fairly quickly (1 to 2 weeks).

Oh, so all that wide-bandwidth noise and late-night hedonism has burned out some of your brain-meat, eh? Well, we’ve got organic transistors that mimic the function of human synapses [via NextBigFuture again]… though quite how we’d patch them into your existing wetware is a bit of a mystery at this point. But hey, they’re called NOMFETs, so the internet should find plenty of macro jokes to make about ’em!

A biological synapse transforms a voltage spike (action potential) arriving from a pre-synaptic neuron into a discharge of chemical neurotransmitters that are then detected by a post-synaptic neuron. These are subsequently transformed into new spikes, leading to a succession of pulses that either become larger or diminish in size. This fundamental property of synaptic behaviour is known as short-term plasticity, which is related to a neural network’s ability to learn. It is this plasticity that Vuillaume and colleagues have succeeded in mimicking.

In the NOMFET, the pre-synaptic signal is simply the pulse voltage applied to the device and the output signal is the drain current, explains Vuillaume. The holes – the charge carriers in the p-type organic semiconductor employed – are trapped in the nanoparticles and act like the neurotransmitters. A certain number of holes are trapped for each incoming spike voltage and in the absence of pulses, the holes escape in a matter of seconds

This time delay is carefully adjusted by the researchers by optimizing nanoparticle number and device geometry. “The output of the NOMFET is thus able to reproduce the deceasing or amplifying behaviour typical of a synapse depending on the frequency of spikes,” said Vuillaume.

Er… your health insurance is fully up to date, right? [image by Bistrosavage]

[ * Guess who’s been reading a Sonic Youth biography this week… 🙂 ]

The Tender Mash-up

Since I chose to write about things made of metal skins and electrical guts in November, and then about warm-blooded carbon-based life in December, I couldn’t resist a combination. I call it the tender mash-up because the fusion of man and machine might result in an emotional being with a huge leap forward in physical capacity. The popular television and movie characters Robocop and The Six Million Dollar Man may be coming close to reality. Continue reading The Tender Mash-up

Fake blood

red blood cellsNo, not the Halloween dress-like-a-zombie fake blood – we’re talking entirely artificial polymer replacements for red blood cells, which could potentially be used for transfusions in the absence of donated blood [image by Andrew Mason]:

They start out as spherical cells which then collapse into mature red blood cells following exposure to various substances. Similarly, Mitragotri’s team found that if they added small balls made of a polymer called PLGA to a particular solvent, the spheres would collapse into a biconcave shape.

The researchers coated these 7-micrometre across, tyre-shaped particles, in a layer of protein. When they dissolved away the polymer core, a soft biodegradable protein shell was left behind with the same mechanical properties as red blood cells.

The fake cells also seem to share red blood cells’ ability to transport substances. One of the proteins Mitragotri added to the surface of the imitation blood cells was haemoglobin, the molecule that binds to oxygen in the lungs, later releasing it elsewhere in the body.

In test tube experiments, the researchers found that their haemoglobin-coated particles picked up oxygen when there was a lot around and released it later when the concentration was lower. If the squishy particles do the same thing when injected in animals, they could be given to people instead of a blood transfusion.

To see if the protein shells could also carry drugs, Mitrogotri’s team exposed them to the anti-clotting drug heparin. Sure enough, the particles soaked up the heparin and then released it later on when they were moved to an area of lower concentration.

Want to stave off swine flu? Catch a cold

sneezeOK, before anyone says it, the headline is not to be taken as medical advice (I am not a doctor, nor do I play one on television, etc, etc). But research into surprisingly low incidences of swine flu in France in recent months suggests that the common cold may be suppressing the ability of the H1N1 virus to get a toe-hold in our immune systems. [image by trumanlo]

… the percentage of throat swabs from French respiratory illnesses that tested positive for swine flu fell in September, while at the same time rhinovirus, which causes colds, rose […] in late October, rhinovirus fell – at the same time as flu rose. He suspects rhinovirus may have blocked the spread of swine flu via a process called viral interference.

This is thought to occur when one virus blocks another. “We think that when you get one infection, it turns on your antiviral defences, and excludes the other viruses,” says Ab Osterhaus at the University of Rotterdam in the Netherlands.

How important such interference is in viral epidemics is unclear, however: there are also cases in which there is no interference, and people catch two viruses at the same time. Normally, we don’t get a chance to see how rhinovirus affects flu, as flu epidemics usually strike in winter, whereas rhinovirus hits when schools start (late summer in the northern hemisphere).

In other words, the effect isn’t fully understood, or even well enough understood to provide some sort of solution. But it might provide a starting point…

So why hasn’t the US, for example, seen a dip in pandemic cases during a back-to-school rhinovirus outbreak? Mackay speculates that interference from rhinovirus may not be enough to fend off flu if someone is exposed repeatedly. There were far more cases of swine flu in the US in September than in Europe.

The effects of rhinovirus, often dismissed as “only” a cold, are too poorly understood, say all the researchers. Its seeming ability to block swine flu may already have saved lives in France by buying the nation time before the vaccine arrived. It may even lead to a drug that induces the antiviral state, but without the sniffles.

Fight fire with fire, as the old saying goes.